Get in touch
Questions about growing, workshops, the cooperative or partnerships? Send us a message and we will reply by email.
Prefer email? Write to erasmus@evec.org.gr
Red radish microgreens (RRM) have gained considerable attention for their promising therapeutic potential. However, the molecular mechanisms underlying the
Trina Ekawati Tallei, Nova Hellen Kapantow, Nurdjannah Jane Niode, Sofia Safitri Hessel, Maghfirah Savitri, Fatimawali Fatimawali, Sojin Kang, Moon Nyeo Park, Muhammad Raihan, Widya Hardiyanti, Firzan Nainu, Bonglee Kim
Scientific Reports · 2025 · https://doi.org/10.1038/s41598-025-02999-5
Red radish microgreens (RRM) have gained considerable attention for their promising therapeutic potential. However, the molecular mechanisms underlying their bioactivity remain inadequately characterized. This study explores the anti-inflammatory, antioxidant, and anticancer properties of RRM extract using in silico and in vivo Drosophila model analyses. The metabolite profile of the RRM extract was characterized using comprehensive metabolomics techniques, including Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography High-Resolution Mass Spectrometry (LC-HRMS). Furthermore, in silico analysis utilizing network pharmacology identified target proteins of RRM compounds associated with cancer, inflammation, and oxidative stress. Concurrently, in vivo experiments with Drosophila melanogaster PGRP-LB Δ (Dm PGRP-LB Δ ) larvae was conducted to assess the extract’s impact on immune and oxidative stress pathways. In silico analysis revealed that RRM compounds interacted with key proteins (AKT1, ESR1, MAPK1, SRC, TP53), modulating pathways related to cancer, inflammation, and oxidative stress. Molecular dynamics simulations reinforced the docking results by confirming robust binding of kaempferitrin to AKT1. In vivo studies showed that RRM extract suppressed immune-related genes ( dptA , totA ) through the NFκB and JAK-STAT pathways, reduced ROS levels, and selectively regulated antioxidant gene expression by enhancing sod1 while decreasing sod2 and cat. These results suggest RRM extract as a functional food for managing oxidative stress, inflammation, and cancer. Further research in higher organisms and clinical settings is needed.
| Licence | CC-BY-NC-ND-4.0 |
|---|---|
| May we host this PDF? | Yes |
| May we publish a plain-language summary? | No. This licence forbids derivative works. We may report and cite its findings, but not republish a rewritten version. |
| Commercial use permitted? | No — non-commercial use only |
| Share-alike required? | No |
Trina Ekawati Tallei; Nova Hellen Kapantow; Nurdjannah Jane Niode; Sofia Safitri Hessel; Maghfirah Savitri; Fatimawali Fatimawali; Sojin Kang; Moon Nyeo Park; Muhammad Raihan; Widya Hardiyanti; Firzan Nainu; Bonglee Kim (2025). Integrative in silico and in vivo Drosophila model studies reveal the anti-inflammatory, antioxidant, and anticancer properties of red radish microgreen extract. Scientific Reports. https://doi.org/10.1038/s41598-025-02999-5 Licensed under Creative Commons Attribution NC ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/). Hosted by EVEC Athens (microgreens.org.gr). No changes were made to this article. Provided as-is, without warranties. EVEC Athens is not affiliated with, and this copy is not endorsed by, the authors or the publisher.
This is a copy of the published article, hosted by EVEC Athens for free educational use under its open licence. The permanent scientific reference is the DOI above. We have not altered the file in any way. If you are an author or rights holder and want this copy removed, please use our notice and takedown procedure. We acknowledge every request within five working days, and act within ten.
Co-funded by the European Union.
This portal presents the microgreens methodology; the organisation behind it is EVEC Athens — the European Voluntary and Educational Center (evec.org.gr). Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.
Open licence. Except where stated otherwise, the educational materials on this portal are licensed under CC BY 4.0 — free to use, adapt and share, including commercially, with credit. See the licence terms.
Accessibility. We aim for WCAG 2.1 AA and publish what does and does not yet meet it — see the accessibility statement. If anything here blocks you, tell us and we will send the material in a format that works for you.